Cheiranthus cheiri Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Cruciferae; Brassicaceae. |
| Habitat | Native to South Europe, grown as an ornamental. |
| English | Wall-flower, Gilli Flower. |
| Unani | Tudri (Surkh, Safed, Zard) |
| Action | Flowers—cardioactive, tonic, antispasmodic, purgative, emmenagogue, deobstruent (used in liver diseases and sexual debility). Seeds— stomachic, diuretic, expectorant (in bronchitis and asthma); also goitrogenic. Juice of leaves and seeds—antibacterial. |
| Taxonomic Cohort | Genus Cheiranthus (1 documented species); Family Cruciferae (18 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Cheiranthus cheiri (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Cruciferae; Brassicaceae (primary family classification: Cruciferae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Native to South Europe, grown as an ornamental.
Across classical and vernacular Indian systems of medicine, Cheiranthus cheiri is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Wall-flower, Gilli Flower; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Tudri (Surkh, Safed, Zard). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cheiranthus cheiri are: Flowers—cardioactive, tonic, antispasmodic, purgative, emmenagogue, deobstruent (used in liver diseases and sexual debility). Seeds— stomachic, diuretic, expectorant (in bronchitis and asthma); also goitrogenic. Juice of leaves and seeds—antibacterial. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cheiranthus cheiri establish the following evidence base: Flowers contain flavonoids (quercetin and rhamnetin derivatives); seeds contain high levels of cardiac aglycones (30 cardiac glycosides have been isolated); oil contains cherinine, a glucoside of the digitalis group. In Unani medicine, the drug is used as a tonic to the male reproductive system, but recent findings do not validate its therapeutic use. The flavonoid, kaempferol, isolated from the young plant, inhibits spermatogenesis and alters leydig cell number and diameter, affecting the fertility.

Botanical Reference 1: Erysimum cheiri — Botanical specimen

Botanical Reference 2: Erysimum cheiri — Botanical specimen

Botanical Reference 3: Cheiranthus cheiri — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Cheiranthus cheiri stands as a distinct representative of the genus Cheiranthus. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Cruciferae encompasses 18 documented medicinal species (0.99% of the 1,814-species flora). Other representative medicinal members of Cruciferae include: Anastatica hierochuntica Linn. (Jericho Rose), Armoracia lapathifolia (Horseradish), Brassica alba (Siddhaartha), Brassica campestris rapa (Sarshapa), Capsella bursa-pastoris (Shepherd’s Purse). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 18 medicinal species of family Cruciferae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Cheiranthus cheiri follow the plant-part modalities specified under its therapeutic action (Flowers—cardioactive, tonic, antispasmodic, purgative, emmenagogue, deobstruent (used in liver diseases and sexual debility). Seeds— stomachic, diuretic, expectorant (in bronchitis and asthma); also goitrogenic. Juice of leaves and seeds—antibacterial), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Cheiranthus cheiri integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.